Claude Knopf has been appointed chief business officer of Pieris Pharmaceuticals Inc, a Nasdaq listed oncology company that is developing protein therapeutics based on German technology. Mr Knopf previously headed business development at Baxalta, which is now part of Shire Plc. Prior to that he was an executive at Novartis, most recently as head of business development for vaccines in Europe.
Mr Knopf received a Master’s degree in international business studies from the Moore School of Business at the University of South Carolina, US.
Pieris announced the appointment on 1 December 2016.
Copyright 2016 Evernow Publishing Ltd